Nintedanib Leman 100 mg

Nintedanib Leman 100 mg is a medicine authorised by Swissmedic under authorisation number 70464. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 March 2026 and the authorisation is limited until 02 March 2031. ATC code L01EX09 places the medicine in the group Antineoplastic agents.

  • Dispensing category B
  • Authorisation number 70464
  • ATC L01EX09
  • Synthetic medicines
Authorisation data
Authorisation number70464
NameNintedanib Leman 100 mg
Full nameNintedanib Leman 100 mg, capsule molle
Authorisation holderLeman SKL SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL01EX09
First authorisation03 March 2026
Authorisation validity02 March 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Nintedanib Leman 100 mg, capsule molleB03 March 2026
2Nintedanib Leman 150 mg, capsule molleB03 March 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Kapsel(n)L01EX0903.99.0.B
260Kapsel(n)L01EX0903.99.0.B
330Kapsel(n)L01EX0903.99.0.B
460Kapsel(n)L01EX0903.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Nintedanib Leman 100 mg authorised in Switzerland?

Yes. Nintedanib Leman 100 mg is authorised by Swissmedic under authorisation number 70464, data as of 01 September 2026. The authorisation is limited until 02 March 2031.

Which dispensing category does Nintedanib Leman 100 mg have?

Nintedanib Leman 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Nintedanib Leman 100 mg?

The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com